Study of Immediate Start of Progestin Contraceptives in Medical Abortion
Overview
This study will compare immediate to post-abortion start of two progestin-based contraceptives (DMPA and etonorgestrel implants) among women having first trimester medical abortion who wish to use that method for post-abortion contraception.
Full Title of Study: “Immediate Initiation of Progestin Contraceptives in First Trimester Medical Abortion: A Randomized Controlled Trial”
Study Type
- Study Type: Interventional
- Study Design
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Primary Purpose: Prevention
- Masking: None (Open Label)
- Study Primary Completion Date: December 2015
Interventions
- Other: Timing of Contraceptive Initiation in Medical Abortion
Arms, Groups and Cohorts
- Active Comparator: Quickstart
- Immediate start
- Active Comparator: Afterstart
- Delayed start
Clinical Trial Outcome Measures
Primary Measures
- Medical Abortion Failure
- Time Frame: One month after enrollment
- Repeat Pregnancy
- Time Frame: 6 months after enrollment
Participating in This Clinical Trial
Inclusion Criteria
Women having medical abortion desiring progestin-based contraceptives (injectables or implants)
Gender Eligibility: Female
Minimum Age: N/A
Maximum Age: N/A
Are Healthy Volunteers Accepted: Accepts Healthy Volunteers
Investigator Details
- Lead Sponsor
- Gynuity Health Projects
- Provider of Information About this Clinical Study
- Sponsor
Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.